vs

Side-by-side financial comparison of VisionWave Holdings, Inc. (VWAV) and Wave Life Sciences Ltd. (WVE). Click either name above to swap in a different company.

VisionWave Holdings, Inc. is the larger business by last-quarter revenue ($10.0M vs $8.7M, roughly 1.1× Wave Life Sciences Ltd.). VisionWave Holdings, Inc. runs the higher net margin — -69.4% vs -580.2%, a 510.8% gap on every dollar of revenue.

CoMix Wave Films, Inc. is a Japanese independent animation film studio and distribution company based in Chiyoda, Tokyo, Japan. The studio is known for its anime feature films, short films, and television commercials, particularly those made by director Makoto Shinkai. It was founded in March 2007 when it split from CoMix Wave Inc., which was initially formed in 1998 from Itochu Corporation, ASATSU, and other companies. On 15 October 2024, Toho announced that they'd acquired 45 shares or 6.0...

BIT Life Sciences is a for profit meetings, incentives, conferencing, exhibitions (MICE) company based in Dalian, China, that specializes in arranging multiple scientific congresses that have been described as "predatory". The company is part of a wave of organizations that have appeared in China in the past several years noted for arranging congresses with little academic merit and with the primary aim of generating revenue rather than scientific knowledge sharing. Papers submitted are usual...

VWAV vs WVE — Head-to-Head

Bigger by revenue
VWAV
VWAV
1.1× larger
VWAV
$10.0M
$8.7M
WVE
Higher net margin
VWAV
VWAV
510.8% more per $
VWAV
-69.4%
-580.2%
WVE

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
VWAV
VWAV
WVE
WVE
Revenue
$10.0M
$8.7M
Net Profit
$-6.9M
$-50.5M
Gross Margin
Operating Margin
-65.7%
-606.5%
Net Margin
-69.4%
-580.2%
Revenue YoY
-55.8%
Net Profit YoY
-1522.6%
-53.3%
EPS (diluted)
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
VWAV
VWAV
WVE
WVE
Q4 25
$10.0M
Q2 25
$8.7M
Q1 25
$9.2M
Q2 24
$19.7M
Q1 24
$12.5M
Q4 23
$29.1M
Q3 23
$49.2M
Q2 23
$22.1M
Net Profit
VWAV
VWAV
WVE
WVE
Q4 25
$-6.9M
Q2 25
$-50.5M
Q1 25
$-46.9M
Q2 24
$-32.9M
Q1 24
$-31.6M
Q4 23
$-16.3M
Q3 23
$7.3M
Q2 23
$-21.1M
Operating Margin
VWAV
VWAV
WVE
WVE
Q4 25
-65.7%
Q2 25
-606.5%
Q1 25
-542.8%
Q2 24
-177.7%
Q1 24
-274.8%
Q4 23
-64.3%
Q3 23
9.0%
Q2 23
-106.2%
Net Margin
VWAV
VWAV
WVE
WVE
Q4 25
-69.4%
Q2 25
-580.2%
Q1 25
-510.9%
Q2 24
-167.2%
Q1 24
-251.7%
Q4 23
-55.9%
Q3 23
14.7%
Q2 23
-95.5%
EPS (diluted)
VWAV
VWAV
WVE
WVE
Q4 25
Q2 25
$-0.31
Q1 25
$-0.29
Q2 24
$-0.25
Q1 24
$-0.24
Q4 23
$-0.14
Q3 23
$0.07
Q2 23
$-0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
VWAV
VWAV
WVE
WVE
Cash + ST InvestmentsLiquidity on hand
$15.7K
$208.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$3.1M
$139.3M
Total Assets
$18.4M
$252.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
VWAV
VWAV
WVE
WVE
Q4 25
$15.7K
Q2 25
$208.5M
Q1 25
$243.1M
Q2 24
$154.0M
Q1 24
$180.9M
Q4 23
$200.4M
Q3 23
$139.9M
Q2 23
$173.0M
Stockholders' Equity
VWAV
VWAV
WVE
WVE
Q4 25
$3.1M
Q2 25
$139.3M
Q1 25
$171.8M
Q2 24
$-3.5M
Q1 24
$25.4M
Q4 23
$39.6M
Q3 23
$-40.5M
Q2 23
$-51.7M
Total Assets
VWAV
VWAV
WVE
WVE
Q4 25
$18.4M
Q2 25
$252.4M
Q1 25
$288.3M
Q2 24
$208.8M
Q1 24
$235.3M
Q4 23
$274.9M
Q3 23
$199.9M
Q2 23
$230.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
VWAV
VWAV
WVE
WVE
Operating Cash FlowLast quarter
$-5.4M
$-46.0M
Free Cash FlowOCF − Capex
$-46.3M
FCF MarginFCF / Revenue
-532.5%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-170.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
VWAV
VWAV
WVE
WVE
Q4 25
$-5.4M
Q2 25
$-46.0M
Q1 25
$-63.0M
Q2 24
$-27.5M
Q1 24
$-33.4M
Q4 23
$-33.2M
Q3 23
$-34.5M
Q2 23
$-37.3M
Free Cash Flow
VWAV
VWAV
WVE
WVE
Q4 25
Q2 25
$-46.3M
Q1 25
$-63.2M
Q2 24
$-27.5M
Q1 24
$-33.8M
Q4 23
$-33.6M
Q3 23
$-34.7M
Q2 23
$-37.3M
FCF Margin
VWAV
VWAV
WVE
WVE
Q4 25
Q2 25
-532.5%
Q1 25
-688.9%
Q2 24
-139.8%
Q1 24
-270.0%
Q4 23
-115.6%
Q3 23
-70.4%
Q2 23
-168.9%
Capex Intensity
VWAV
VWAV
WVE
WVE
Q4 25
Q2 25
3.5%
Q1 25
1.8%
Q2 24
0.3%
Q1 24
3.3%
Q4 23
1.2%
Q3 23
0.4%
Q2 23
0.3%
Cash Conversion
VWAV
VWAV
WVE
WVE
Q4 25
Q2 25
Q1 25
Q2 24
Q1 24
Q4 23
Q3 23
-4.75×
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons